Skip to main content

The link between type 1 diabetes and MASLD

A growing subset of patients with type 1 diabetes are developing insulin resistance, which may accelerate progression toward steatohepatitis, fibrosis, and CV complications via unique mechanisms.

Read more

Editor's Choice

What's driving cmHFpEF?

Understand the critical role of immunometabolic dysregulation, chronic inflammation, oxidative stress, and epigenetic regulation in cardiometabolic heart failure with preserved ejection fraction

Management of monogenic obesity due to congenital leptin deficiency

A woman with morbid obesity caused by a homozygous mutation in the LEP gene achieved a reduction in BMI of 40 kg/m2 and improvement in associated metabolic comorbidities after 4 years of metreleptin therapy.

International expert consensus on surgery for type 2 diabetes

Guidance for clinicians on various aspects of metabolic surgery for type 2 diabetes, from terminology and mechanisms of action to predictors of remission, monitoring and special considerations, and remission and recurrence.

Isolated hypothyroxinemia linked to gestational diabetes risk

Low free thyroxine levels and isolated hypothyroxinemia, but not subclinical hypothyroidism, are associated with an increased risk for gestational diabetes.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

ADA 2025: the 85th Scientific Sessions

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s annual meeting.

Read more

Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.

Supported by: Abbott Diabetes Care

Log in / Register to watch the full video

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by:
  • Abbott Diabetes Care
Prof. Samuel Seidu
Developed by: Adis
Listen now
Podcast

Case Studies

Management of monogenic obesity due to congenital leptin deficiency

A woman with morbid obesity caused by a homozygous mutation in the LEP gene achieved a reduction in BMI of 40 kg/m2 and improvement in associated metabolic comorbidities after 4 years of metreleptin therapy.

Ketoacidosis in a man with type 1 diabetes treated with tirzepatide

Vigilance is key in people with type 1 diabetes who take tirzepatide. In this patient, ketoacidosis developed after malaise, aphagia, and malnutrition decreased his insulin requirements and he couldn’t manage his pump and sensor.

Sequential bilateral RAO in a diabetic patient

Metabolic disorders, like hyperlipidemia and diabetes, are high-risk factors for developing retinal artery occlusion. Timely intra-arterial thrombolysis in this case was crucial for preserving the patient's vision.

Episode 19: GLP-1 medicines - past, present, and future

From diabetes to obesity and beyond

In 2005 the US FDA approved the first GLP-1 medicine for type 2 diabetes, marking the start of a remarkable journey that goes beyond the stimulation of insulin secretion.

Prof. Daniel Drucker gives us a fascinating insight into the early work on GLP-1 and discusses how these medicines are impacting the lives of people with diabetes and obesity. He covers what's known about how they work, treatment duration, side effects, and the role of bariatric surgery, plus what's in the pipeline in terms of drug development and the indications that GLP-1 medicines may be used to treat in the future.

Prof. Daniel Drucker
Listen now
Podcast

Current Reviews

Elucidating programmed cell death in diabetic retinal microangionopathy and neurodegeneration: unraveling molecular mechanisms and therapeutic actions of natural products

Diabetic retinopathy (DR) is a common diabetes condition that contributes significantly to vision impairment and blindness in working-age people. The classical theory contends that DR is solely a retinal microvascular disorder. Nevertheless, a …

GLP1-RA and SGLT2-i: Implementation and Insulin Deescalation Strategies

Cardiovascular disease (CVD) remains the leading cause of death in the USA, accounting for 928,741 deaths in the year 2024. Coronary artery disease (CAD) led at 40.3% of the deaths attributable to CVD, followed by stroke, other minor CVD causes …

2023 European Society of Cardiology guidelines for the management of cardiovascular disease in patients with diabetes

The 2023 update of the European Society of Cardiology guidelines for the management of cardiovascular disease (CVD) in patients with diabetes are designed to guide prevention, early diagnosis, and management of CVD in patients with diabetes and …

Advances in genome-wide association studies of type 2 diabetes across populations:   A systematic review

Type 2 diabetes mellitus (T2DM), previously referred to as non-insulin dependent diabetes mellitus (NIDDM) or maturity onset diabetes (MOD), represents more than 90% of all diabetes cases globally [ 1 ]. It is a complex metabolic disorder primarily …

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

CME & eLearning

Vodcast

Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.

Supported by:
  • Abbott Diabetes Care
Developed by: Springer Health+

Videos | Case Scenarios | Infographics (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.

Supported by:
  • Abbott
Developed by: Springer Health+ IME

Vodcasts | Case Scenarios (Link opens in a new window)

Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Health+ IME

Further Reading

Impact of diabetes mellitus on spinal injection two-week outcomes in patients with predominant lower extremity pain

  • Open Access
  • Diabetes
  • Scientific Article

Diabetes mellitus (DM) is becoming increasingly prevalent in the United States, affecting approximately 38.4 million individuals (11.6% of the population) [ 1 ]. This rise in diabetes cases spans various social, economic, and ethnic backgrounds …

Effectiveness of Glipizide and Glipizide Plus Metformin Formulation among Asian Indians with Type 2 Diabetes: a Real‐World, Retrospective Electronic Medical Record Analysis

  • Open Access
  • Glipizide
  • Original Research Article

Type 2 diabetes (T2D) is a chronic metabolic disorder characterized by insulin resistance and progressive β-cell dysfunction, resulting in impaired glucose metabolism [ 1 ]. It represents a significant public health challenge globally, with an …

GLP1-RA and SGLT2-i: Implementation and Insulin Deescalation Strategies

Cardiovascular disease (CVD) remains the leading cause of death in the USA, accounting for 928,741 deaths in the year 2024. Coronary artery disease (CAD) led at 40.3% of the deaths attributable to CVD, followed by stroke, other minor CVD causes …

Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study

Rapid tightening of glycaemic control in individuals receiving intensive treatment for diabetes can lead to paradoxical early exacerbation of diabetic retinopathy [ 1 ]. Early worsening of diabetic retinopathy (EWDR) was first reported in …

Related topics

The link between type 1 diabetes and MASLD

A growing subset of patients with type 1 diabetes are developing insulin resistance, which may accelerate progression toward steatohepatitis, fibrosis, and CV complications via unique mechanisms.

Read more

The link between type 1 diabetes and MASLD

A growing subset of patients with type 1 diabetes are developing insulin resistance, which may accelerate progression toward steatohepatitis, fibrosis, and CV complications via unique mechanisms.

Read more

Ketoacidosis in a man with type 1 diabetes treated with tirzepatide

Vigilance is key in people with type 1 diabetes who take tirzepatide. In this patient, ketoacidosis developed after malaise, aphagia, and malnutrition decreased his insulin requirements and he couldn’t manage his pump and sensor.

Read more